对遗传性非多重性结直肠癌的基因测试结果的解释:对临床倾向性测试的含义
1Brigham and Women's Hospital, Department of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Mass 02115, USA.
JAMA
|July 28, 1999
概括
遗传性非多性结直肠癌 (HNPCC) 的遗传检测在25.7%的家庭中发现了致病突变,有助于临床管理. 然而,对于许多人来说,最终的解释仍然是一个挑战,需要持续的监督.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 对癌症倾向的基因测试正在从研究转向临床实践.
- 遗传性非多重性结直肠癌 (HNPCC) 是一种重要的遗传性癌症综合征.
研究的目的:
- 评估HNPCC遗传测试结果的可解释性和临床实用性.
- 确定怀疑HNPCC的家庭中确定的遗传测试结果的频率.
主要方法:
- 在70个家族中对hMSH2和hMLH1基因进行序列分析.
- 将突变分类为蛋白质截断或误解,并对误解变化进行进一步分析.
- 基于诊断标准 (阿姆斯特丹,贝塞斯达) 和临床表现的家庭分类.
主要成果:
- 在24个家庭中发现了27个变化 (34.3%).
- 在18个家族 (25.7%) 中确定了可用于临床管理的确定的致病突变.
- 由于误解突变和有限的功能测试,特别是在不符合严格HNPCC标准的家庭中,发现了解释挑战.
结论:
- 对HNPCC的遗传测试对于识别家族子集中的致病突变,指导临床管理是有价值的.
- 对于那些基因测试结果不确定性的家庭来说,持续的密集跟踪至关重要.
- 这项研究强调了需要改进的方法来解释HNPCC中的遗传变异.
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...


